Frank Clark

Chief Financial Architect

Frank is also the original co-founder of CytoSorbents, Inc.(NASD: CTSO), a medical device company that has developed a novel hemoperfusion device for blood purification used in COVID-19, critical care medicine and cardiac surgery. Frank raised more than $50 million for the company and established critical relationships with Fortune 500 business partners and medical thought leaders. He also built the management team, led business development, negotiated vendor and distribution deals for the company, and managed investor relations.